Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients.
Mandó P, Rizzo M, Roberti MP, Juliá EP, Pampena MB, Pérez de la Puente C, Loza CM, Ponce C, Nadal J, Coló FA, Mordoh J, Levy EM. Mandó P, et al. Among authors: colo fa. Onco Targets Ther. 2018 May 17;11:2901-2910. doi: 10.2147/OTT.S160911. eCollection 2018. Onco Targets Ther. 2018. PMID: 29844687 Free PMC article.
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients.
Roberti MP, Rocca YS, Amat M, Pampena MB, Loza J, Coló F, Fabiano V, Loza CM, Arriaga JM, Bianchini M, Barrio MM, Bravo AI, Domenichini E, Chacón R, Mordoh J, Levy EM. Roberti MP, et al. Breast Cancer Res Treat. 2012 Dec;136(3):659-71. doi: 10.1007/s10549-012-2287-y. Epub 2012 Oct 14. Breast Cancer Res Treat. 2012. PMID: 23065032
Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair-Related Genes.
Bruno L, Ostinelli A, Waisberg F, Enrico D, Ponce C, Rivero S, Blanco A, Zarba M, Loza M, Fabiano V, Amat M, Pombo MT, Noro L, Chacón M, Coló F, Chacón R, Nadal J, Nervo A, Costanzo V. Bruno L, et al. JCO Precis Oncol. 2022 Mar;6:e2100140. doi: 10.1200/PO.21.00140. JCO Precis Oncol. 2022. PMID: 35235412
The role of modern parameters and their relationship with recurrence risk as assessed by Oncotype DX: real-world evidence.
Narvaez D, Nadal J, Nervo A, Costanzo V, Paletta C, Petracci F, Rivero S, Ostinelli A, Coló F, Martín L, Fabiano V, Sabatini L, Perazzolo A, Amat M, Chacon M, Waisberg F. Narvaez D, et al. Ecancermedicalscience. 2024 Feb 6;18:1664. doi: 10.3332/ecancer.2024.1664. eCollection 2024. Ecancermedicalscience. 2024. PMID: 38439804 Free PMC article.
Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America.
Gomez HL, Bargallo-Rocha JE, Billinghurst RJ, Núñez De Pierro AR, Coló FA, Gil LLB, Allemand C, McLean IL, Lema-Medina M, Herazo-Maya F, Terrier FJ, Cwilich RG, Leon M, Falcon SG, Castaño RE, Oliveira SC, Jakubowski DM, Chao C. Gomez HL, et al. Among authors: colo fa. JCO Glob Oncol. 2021 Aug;7:1364-1373. doi: 10.1200/GO.21.00008. JCO Glob Oncol. 2021. PMID: 34506221 Free PMC article.
12 results